We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Multiple Trial Designs, Endpoints May Be Best for CF Treatments
Multiple Trial Designs, Endpoints May Be Best for CF Treatments
September 29, 2010
No one trial design or endpoint is optimal for inhaled antibiotics for cystic fibrosis (CF) patients infected with a chronic bacterial infection, a CF researcher says.